Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia
Emily Chiu, Martin Felices, Frank Cichocki, Zachary Davis, Hongbo Wang, Katie Tuninga, Daniel A. Vallera, Tom Lee, Ryan Bjordahl, Karl‐Johan Malmberg, Bahram Valamehr, Jeffrey S. Miller
Topics & Concepts
DegranulationLymphokine-activated killer cellCytotoxic T cellCell biologyNK-92BiologyInterleukin 21ChemistryCancer researchImmunologyReceptorImmune systemT cellIn vitroBiochemistryImmune Cell Function and InteractionCAR-T cell therapy researchT-cell and B-cell Immunology